Celsion Corporation CLSN shares are trading lower by $1.00 (16 percent) at $5.06 in Wednesday's session.
The stock, which rallied 300 percent on Tuesday ($1.50 to $6.06) off positive drug trial results, was hit with a wave sellers off the open.
After $2.00 lower open, Celsion's stock went another 25 cents lower bottoming at $3.76 and reversed course. So far, the ensuing rally has taken the stock to $5.28 and is attempting to remain in the $5.00 handle.
Some traders attribute the move higher to speculation that Maxim upgraded the stock to Buy.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.